markers, pointed towards atypical FMF, as indicated by genetic testing showing a heterozygous MEFV mutation (MET694val). This mutation is typically associated with carrier status rather than severe disease. This case
tailor therapies that are more effective and less toxic. These biomarkers can identify mutations, alterations in gene expression, and other molecular changes that drive cancer progression, helping to predict
stimulates the immune system. This technology allows for faster vaccine development, flexibility in addressing mutating pathogens, and the ability to target diseases that have been difficult to address using conventional
impact of genetic markers on the diagnosis, progression, and management of bladder cancer. Genetic mutations, such as those involving the FGFR3, TP53, and RB1 genes, are increasingly recognized for their
Bladder cancer progression is influenced not only by the genetic mutations within tumor cells but also by the dynamic interactions between the tumor and its surrounding microenvironment. The tumor microenvironment
most common form of dwarfism. It is a genetic disorder that occurs due to mutation of Fibroblast Growth Factor Receptor (FGFR3). Following is a case report of a patient with
cellular systems that safeguard genomic integrity and regulate cellular growth, division, and apoptosis. Mutations or inactivation of these genes can lead to uncontrolled cell proliferation and cancer development. This…
diagnostics, have significantly improved the accuracy of tumor characterization and the identification of genetic mutations, facilitating personalized treatment approaches. The recognition of specific biomarkers, like…
novel insights into the mechanisms of brain function. By studying the interactions between genetic mutations, variations, and the nervous system, neurogenetics seeks to uncover the causes of neurological and psychiatric…
Marfan Syndrome (MFS) is a congenital systemic connective tissue disorder. It is caused by mutations in the fibrillin-1 gene, a structural protein found in many tissues. The defects lead
that exposure to airborne nanoparticles can lead to genotoxic effects, which may result in mutations, cancer, and other adverse health outcomes. This article reviews the sources of airborne nanoparticles
cancer science. Oncogenes, such as RAS and MYC, were identified as genes that, when mutated, drive cancer development. Tumor suppressor genes, like p53 and BRCA1, were found to play ... personalized medicine. By…
treatment of bacterial infections. Most antibiotic resistance has emerged as a result of mutation or through the transfer of genetic material between microorganisms. Some studies on bacterial resistance have shown…
Inherited cardiomyopathies are a diverse group of heart muscle diseases caused by genetic mutations that result in structural and functional abnormalities of the myocardium. Understanding genotype-phenotype correlations…
represents a paradigm shift in the treatment of advanced thyroid cancers, addressing specific genetic mutations and pathways. Additionally, therapies like Thyrogen streamline diagnostic procedures, improving patient…
ThyraMIR, though less studied, presents promising results, particularly in miRNA analysis for weak driver mutations. Challenges in interpreting results include variations in reporting and the evolving nature of testing…
review examines recent advancements in ctDNA research, including the role of key genetic mutations and copy number alterations, and highlights the need for improved assay sensitivity and specificity. It also
with molecular assays have failed to show clinical benefit, while investigations of actionable targetable mutations are hampered by the significant molecular heterogeneity of CUP. Liquid biopsies, due to their inherent
evaluate the potential pathogenic or benign consequences of the Liver Kinase B1 (LKB1) protein mutation, Mitogen Activated Protein Kinase p38alpha (D176A), which is categorized as a Variant of Unknown Significance…
Monogenic diabetes, a rare form of diabetes resulting from single-gene mutations, poses unique challenges during pregnancy. Unlike the more common forms of diabetes (Type 1 and Type 2), monogenic
advanced sequencing technologies. We then examine the role of ctDNA in identifying genetic mutations, tracking tumor evolution, and predicting treatment outcomes. The review highlights significant advancements in ctDNA…
NKCC2 and their implications for Bartter Syndrome and blood pressure homeostasis. We explore how mutations or dysfunctions in these quality control processes can lead to altered NKCC2 function, contributing
sensorineural deafness, alterations eye problems (ocular lenticone former) and progression to endstage renal disease. Mutations in the COL4A5 gene are responsible for sex-linked syndrome, which represent ... highlight…
PCCs is not reported. The aim of this study is to report the mutational difference and assess the feasibility of Next Generation Sequencing (NGS) testing by Circulating Tumor DNA (ctDNA ... were present in 16 (67%) PGLs…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.